Image is for illustration only. Actual medication labels identify the licensed compounding pharmacy that dispenses your prescription; DirectRxCare is not a pharmacy and does not compound medications.
- Clinically proven to reduce body weight by up to 15%
- Suppresses appetite and reduces cravings
- Improves blood sugar regulation
- Once-weekly self-injection
- Personalized dosing protocol
- Unlimited clinical support included
Semaglutide
Helps curb appetite & supports steady weight loss
Important Information
- Already taking this medication? If you are not new to this treatment and need to continue at your current dose or move to a higher dose, you will need to provide supporting documentation (such as a recent prescription, pharmacy label, or provider records) showing you have recently been on it. Without this, your provider will start you at the beginning dose.
Compounded Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and blood sugar, leading to significant weight loss results.
Choose Your Plan
100% Money-Back Guarantee if Not Approved. Cancel anytime.
Please note: your medication will arrive in a bottle or vial with the dispensing pharmacy's branding and labeling — packaging may differ from the product image shown.
The Why
Why Semaglutide?
"Because losing weight shouldn't mean losing your mind. Semaglutide quiets the constant noise of cravings and hunger, so you can finally focus on living — not dieting. It's the difference between willpower and science working for you."
"I started Semaglutide because I was tired of yo-yo dieting. Within 3 months, I lost 28 lbs and finally feel in control of my appetite. My energy is through the roof."
Sarah M.
Verified Patient
The Science Behind Semaglutide
One of the most studied weight-management medications in the world
~15%
Avg. body-weight reduction in STEP 1 (68 wks)
17,600+
Adults in the SELECT heart-outcomes trial
1x
Once-weekly dosing
How It Works
Semaglutide mimics GLP-1, a natural hormone released after eating. It signals fullness to the brain, slows how quickly the stomach empties, and helps regulate blood sugar — so smaller portions feel satisfying.
Key Facts
- GLP-1 is a gut hormone first characterized in the 1980s; semaglutide is a long-acting version with a half-life of about one week.
- The active ingredient was first FDA-approved for type 2 diabetes in 2017 and for chronic weight management in 2021.
- Doses are increased gradually (titrated) to help the body adjust and reduce stomach side effects.
- Best outcomes in trials came when medication was combined with reduced-calorie eating and physical activity.
Published Research
STEP 1 Trial
New England Journal of Medicine, 2021
In 1,961 adults with overweight or obesity, once-weekly semaglutide 2.4 mg plus lifestyle changes produced an average body-weight reduction of about 14.9% over 68 weeks, versus about 2.4% with placebo.
SELECT Cardiovascular Outcomes Trial
New England Journal of Medicine, 2023
In more than 17,600 adults with overweight or obesity and established heart disease, semaglutide was associated with a 20% lower risk of major cardiovascular events compared with placebo.
Research summaries describe published studies of the active ingredient and are provided for education only. Compounded medications are not FDA-approved and were not the products studied. Individual results vary; a licensed provider will determine whether treatment is appropriate for you.
FAQ
